Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Translate Bio
Pharma
Tech platforms replacing late-stage drugs as key M&A targets
Companies should reconsider their approach to M&A as the traditional methods of growth are no longer sustainable, says a report from Accenture.
Kevin Dunleavy
Jun 27, 2022 1:35pm
Top 10 biopharma M&A deals in 2021
Jan 18, 2022 3:00am
Sanofi aims to create pharma's 'strongest immunology franchise'
Jan 11, 2022 2:14pm
Sanofi refiles $3.2B Translate Bio deal with FTC
Aug 31, 2021 11:05am
